Jaguar Health announces 1-for-25 reverse stock split effective March 24 to meet Nasdaq compliance

Jaguar Health, Inc.

Reverse split at 1-for-25 ratio, effective March 24, 2025 at 12:01 am ET.
Purpose: support compliance with Nasdaq listing standards and attract institutional investors.
No fractional shares; stockholders otherwise entitled to fractional shares receive cash in lieu.
New CUSIP number for post-split common stock is 47010C888.
Stockholder approval obtained at March 13, 2025 special meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.